Literature DB >> 18354489

Transformation of severe congenital neutropenia to early acute lymphoblastic leukemia in a patient with HAX1 mutation and without G-CSF administration or receptor mutation.

S Yetgin, L Olcay, A Koç, M Germeshausen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18354489     DOI: 10.1038/leu.2008.64

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  4 in total

1.  CLPB mutations cause 3-methylglutaconic aciduria, progressive brain atrophy, intellectual disability, congenital neutropenia, cataracts, movement disorder.

Authors:  Saskia B Wortmann; Szymon Ziętkiewicz; Maria Kousi; Radek Szklarczyk; Tobias B Haack; Søren W Gersting; Ania C Muntau; Aleksandar Rakovic; G Herma Renkema; Richard J Rodenburg; Tim M Strom; Thomas Meitinger; M Estela Rubio-Gozalbo; Elzbieta Chrusciel; Felix Distelmaier; Christelle Golzio; Joop H Jansen; Clara van Karnebeek; Yolanda Lillquist; Thomas Lücke; Katrin Õunap; Riina Zordania; Joy Yaplito-Lee; Hans van Bokhoven; Johannes N Spelbrink; Frédéric M Vaz; Mia Pras-Raves; Rafal Ploski; Ewa Pronicka; Christine Klein; Michel A A P Willemsen; Arjan P M de Brouwer; Holger Prokisch; Nicholas Katsanis; Ron A Wevers
Journal:  Am J Hum Genet       Date:  2015-01-15       Impact factor: 11.025

Review 2.  Congenital neutropenia: diagnosis, molecular bases and patient management.

Authors:  Jean Donadieu; Odile Fenneteau; Blandine Beaupain; Nizar Mahlaoui; Christine Bellanné Chantelot
Journal:  Orphanet J Rare Dis       Date:  2011-05-19       Impact factor: 4.123

Review 3.  Kostmann's Disease and HCLS1-Associated Protein X-1 (HAX1).

Authors:  Christoph Klein
Journal:  J Clin Immunol       Date:  2016-12-10       Impact factor: 8.317

4.  A zebrafish model for HAX1-associated congenital neutropenia.

Authors:  Larissa Doll; Narges Aghaallaei; Advaita M Dick; Karl Welte; Julia Skokowa; Baubak Bajoghli
Journal:  Haematologica       Date:  2021-05-01       Impact factor: 9.941

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.